GE HealthCare announced a $35 million cost‑share expansion of its existing contract with the Biomedical Advanced Research and Development Authority (BARDA). The new funding will accelerate the development of artificial‑intelligence‑powered ultrasound technology designed to improve trauma care and emergency preparedness across hospitals and first‑responder networks.
The expansion builds on an initial $44 million BARDA contract signed in October 2023 that also focused on AI‑enabled ultrasound for trauma and emergency settings. By adding $35 million, GE HealthCare is deepening its commitment to this technology and extending the partnership’s scope to include new AI tools for rapid lung and intra‑abdominal injury assessment in high‑pressure environments.
GE HealthCare’s leadership in AI‑enabled medical devices—having secured 100 FDA authorizations over four consecutive years—positions the company to capitalize on the growing market for automated, point‑of‑care imaging. The investment is expected to strengthen the Imaging and Advanced Visualization Solutions segments, which are the primary drivers of the company’s AI strategy, and to reinforce GE HealthCare’s role as a key player in national health security initiatives.
"Responding to a mass casualty incident demands speed, precision and access to care, especially in high‑pressure environments like emergency departments, field hospitals, and medical transport. Our strategic alignment with BARDA enables us to continue to drive ultrasound innovation through advanced AI tools and specialized hardware designed for the front lines of care.” – Philip Rackliffe, President and CEO, Advanced Visualization Solutions, GE HealthCare.
"GE HealthCare has long been at the forefront of ultrasound innovation in emergency medicine, especially at the point‑of‑care. This milestone reflects our shared aspiration to equip clinicians with tools that enhance decision‑making and help improve patient outcomes in even the most challenging scenarios.” – Karley Yoder, CEO, Comprehensive Care Ultrasound, Advanced Visualization Solutions, GE HealthCare.
The market reacted positively to the announcement, with GE HealthCare’s stock rising 2.15 % on the day of the news. Analysts noted that the partnership signals continued confidence in the company’s AI strategy, and BTIG raised its price target to $91 from $87 while maintaining a Buy rating.
The expansion underscores GE HealthCare’s strategic focus on AI‑driven diagnostics and its partnership with a federal agency that prioritizes national health security. By investing in AI‑powered ultrasound, the company is positioning itself to meet the growing demand for rapid, accurate imaging in emergency and trauma settings, while reinforcing its competitive edge in the expanding AI‑diagnostic market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.